Erratum: Triple-negative breast cancers with amplication of JAK2 at the 9p24 locus demonstrate JAK2-specic dependence (Science Translational Medicine (2019) 11, 476, (eaaw6162), 10.1126/scitranslmed.aaw6162)

J. M. Balko, L. J. Schwarz, N. Luo, M. V. Estrada, J. M. Giltnane, D. Dávila-González, K. Wang, V. Sánchez, P. T. Dean, S. E. Combs, D. Hicks, J. A. Pinto, M. D. Landis, F. D. Doimi, R. Yelensky, V. A. Miller, P. J. Stephens, D. L. Rimm, H. Gómez, J. C. ChangM. E. Sanders, R. S. Cook, C. L. Arteaga

Research output: Contribution to journalReview article

Abstract

In the Research Article “Triple-negative breast cancers with amplication of JAK2 at the 9p24 locus demonstrate JAK2-specic dependence,” the authors have provided additional competing interests, and the competing interests statements have been updated. The PDF and HTML (full text) have been corrected.

Original languageEnglish (US)
Article numbereaaw6162
JournalScience translational medicine
Volume11
Issue number476
DOIs
StatePublished - Jan 23 2019

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Erratum: Triple-negative breast cancers with amplication of JAK2 at the 9p24 locus demonstrate JAK2-specic dependence (Science Translational Medicine (2019) 11, 476, (eaaw6162), 10.1126/scitranslmed.aaw6162)'. Together they form a unique fingerprint.

Cite this